Symrise AG (SY1):企業の財務・戦略的SWOT分析

◆英語タイトル:Symrise AG (SY1) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1281
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Ingredients
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥14,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥28,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥43,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Symrise AG (SY1) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Symrise AG (Symrise) offers flavors and fragrances. The company develops, produces and sells flavorings, fragrances, cosmetic active ingredients and raw materials, and functional ingredients and solutions for the cosmetics industry. It provides biofunctional and bioactive ingredients and substances to the health and personal care sector. The company produces its products mainly on the basis of natural raw materials like vanilla, citrus fruits, onions, fish, meat, blossoms and plant materials. It serves perfume, cosmetics, food, pharma and nutritional supplements industries, and manufacturers of household products. The company has operational presence in the Europe, Africa, the Middle East, Asia Pacific, North America and Latin America. Symrise is headquartered in Holzminden, Niedersachsen, Germany.

Symrise AG Key Recent Developments

Mar 13,2019: Symrise successfully continues profitable growth course in 2018

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Symrise AG – Key Facts
Symrise AG – Key Employees
Symrise AG – Key Employee Biographies
Symrise AG – Key Operational Employees
Symrise AG – Major Products and Services
Symrise AG – History
Symrise AG – Company Statement
Symrise AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Symrise AG – Business Description
Business Segment: Flavor
Overview
Performance
Key Stats
Business Segment: Nutrition
Overview
Performance
Key Stats
Business Segment: Scent & Care
Overview
Performance
Key Stats
Geographical Segment: Asia-Pacific
Target Markets
Performance
Geographical Segment: EAME
Target Markets
Performance
Geographical Segment: Latin America
Target Markets
Performance
Geographical Segment: North America
Target Markets
Performance
R&D Overview
Symrise AG – Corporate Strategy
Symrise AG – SWOT Analysis
SWOT Analysis – Overview
Symrise AG – Strengths
Symrise AG – Weaknesses
Symrise AG – Opportunities
Symrise AG – Threats
Symrise AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Symrise AG, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 13, 2019: Symrise successfully continues profitable growth course in 2018
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Symrise AG, Key Facts
Symrise AG, Key Employees
Symrise AG, Key Employee Biographies
Symrise AG, Key Operational Employees
Symrise AG, Major Products and Services
Symrise AG, History
Symrise AG, Subsidiaries
Symrise AG, Key Competitors
Symrise AG, Ratios based on current share price
Symrise AG, Annual Ratios
Symrise AG, Annual Ratios (Cont...1)
Symrise AG, Annual Ratios (Cont...2)
Symrise AG, Interim Ratios
Symrise AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Symrise AG, Performance Chart (2015 - 2019)
Symrise AG, Ratio Charts

★海外企業調査レポート[Symrise AG (SY1):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MYOS RENS Technology Inc (MYOS):企業の財務・戦略的SWOT分析
    Summary MYOS RENS Technology Inc (MYOS RENS), formerly MYOS Corp is a bionutrition and biotherapeutics company that discovers, develops and commercializes products that improve muscle health and function. The company offers fortetropin, a unique bioactive composition derived from fertilized chicken …
  • Black & Veatch Holding Company:企業の戦略・SWOT・財務分析
    Black & Veatch Holding Company - Strategy, SWOT and Corporate Finance Report Summary Black & Veatch Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • LongReach Group Limited:企業の戦略・SWOT・財務情報
    LongReach Group Limited - Strategy, SWOT and Corporate Finance Report Summary LongReach Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Boone Electric Cooperative:企業の戦略的SWOT分析
    Boone Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Harbin Gloria Pharmaceuticals Co Ltd (002437):製薬・医療:M&Aディール及び事業提携情報
    Summary Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produces and markets nutritional drugs. The company’s products include pharmaceutical drugs for treating nutrition disorders, cancer, cardiovascular diseases, antitumor medication, respiratory medication, a …
  • International Fibres Group Ltd:企業の戦略的SWOT分析
    International Fibres Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Oxford Biodynamics Plc-医療機器分野:企業M&A・提携分析
    Summary Oxford Biodynamics Plc (Oxford Biodynamics) is a biotechnology company that discovers and develops biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, …
  • EnBW Energie Baden-Wuerttenberg AG:戦略・SWOT・企業財務分析
    EnBW Energie Baden-Wuerttenberg AG - Strategy, SWOT and Corporate Finance Report Summary EnBW Energie Baden-Wuerttenberg AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Colfax Corp (CFX):石油・ガス:M&Aディール及び事業提携情報
    Summary Colfax Corp (Colfax) is a manufacturing and engineering company. The company supplies a wide range of products, including heavy-duty centrifugal and axial fans, gas compressors, rotary heat exchangers, and centrifugal and positive displacement pumps; and consumable products and equipment for …
  • Laboratory Corp of America Holdings (LH):医療機器:M&Aディール及び事業提携情報
    Summary Laboratory Corp of America Holdings (LabCorp) is a provider of clinical laboratory services and end-to-end drug development support. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics la …
  • Ennis, Inc. (EBF):企業の財務・戦略的SWOT分析
    Ennis, Inc. (EBF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • WABCO Holdings Inc.:企業の戦略・SWOT・財務分析
    WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Japan Trustee Services Bank Ltd:企業のM&A・事業提携・投資動向
    Japan Trustee Services Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Japan Trustee Services Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Banca Sella Holding SpA:企業の戦略的SWOT分析
    Banca Sella Holding SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Rekah Pharmaceutical Industry Ltd (REKA):企業の財務・戦略的SWOT分析
    Rekah Pharmaceutical Industry Ltd (REKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • aap Implantate AG (AAQ):企業の製品パイプライン分析2018
    Summary aap Implantate AG (aap Implantate) is a medical device company, which develops, manufactures and markets trauma products and biomaterials for orthopedic treatment. Its products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosyn …
  • Nippon Sheet Glass Company Limited :企業の戦略・SWOT・財務情報
    Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report Summary Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • meteocontrol GmbH:電力:M&Aディール及び事業提携情報
    Summary Meteocontrol GmbH (meteocontrol) a subsidiary of S.A.G. Solar GmbH & Co. KG, is a renewable energy company which offers photovoltaic monitoring solutions. The company's product portfolio includes data loggers, WEB'logs, portals, sensor system, grid feed-in management or power control, SCADA …
  • ContraFect Corp (CFRX):企業の財務・戦略的SWOT分析
    Summary ContraFect Corp (ContraFect) is a clinical stage biotechnology company that discovers and develops therapeutic protein and antibody products. The company develops products using lysin and monoclonal antibody platforms for the treatment of life threatening, drug-resistant infectious diseases. …
  • Seres Therapeutics Inc (MCRB):企業の財務・戦略的SWOT分析
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆